FindTrial
Sign In

Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the Lung

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00511290
Enrollment
Unknown
Registered
2007-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2007-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Diseases, Occupational Lung Diseases

Keywords

Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases

Brief summary

In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis. The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.

Interventions

OTHERno generic names

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 7-80

Exclusion criteria

* FEV1 \< 75% predicted pO2 \< 75

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026